Protocol 150998-006: "Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration"

Project: Other project

StatusActive
Effective start/end date10/26/155/31/20

Funding

  • Allergan: $9,949.24